Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Roti

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|September 28, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative PhaseBruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki, et al.
Blood|March 22, 2003
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Mirca Lazzaretti, et al.
Acta Neuropathologica Communications|August 27, 2020
New somatic TERT promoter variants enhance the Telomerase activity in GlioblastomaTiziana Pierini, Carlotta Nardelli, Anair Graciela Lema Fernandez, et al.
Bone Marrow Transplantation|August 22, 2019
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cellsLucia Prezioso, Ilenia Manfra, Sabrina Bonomini, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
International Journal of Molecular Sciences|January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative DisordersLuca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Blood|February 4, 2006
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AMLBrunangelo Falini, Niccolò Bolli, Jing Shan, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Blood|April 20, 2021
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemiaDanika Di Giacomo, Roberta La Starza, Paolo Gorello, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|September 28, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative PhaseBruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki, et al.
Blood|March 22, 2003
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Mirca Lazzaretti, et al.
Acta Neuropathologica Communications|August 27, 2020
New somatic TERT promoter variants enhance the Telomerase activity in GlioblastomaTiziana Pierini, Carlotta Nardelli, Anair Graciela Lema Fernandez, et al.
Bone Marrow Transplantation|August 22, 2019
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cellsLucia Prezioso, Ilenia Manfra, Sabrina Bonomini, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
International Journal of Molecular Sciences|January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative DisordersLuca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Blood|February 4, 2006
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AMLBrunangelo Falini, Niccolò Bolli, Jing Shan, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Blood|April 20, 2021
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemiaDanika Di Giacomo, Roberta La Starza, Paolo Gorello, et al.
Pageof 8